Log In
BCIQ
Print this Print this
 

NMI-300

  Manage Alerts
Collapse Summary General Information
Company Nemucore Medical Innovations Inc.
DescriptionEGFR-targeted platinum nanoemulsion
Molecular Target Epidermal growth factor receptor (EGFR)
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationOvarian cancer
Indication DetailsTreat EGFR-positive platinum-resistant overian cancer
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today